• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UBA1 突变的造血干细胞和祖细胞中 VEXAS 炎症途径的早期激活。

Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS.

机构信息

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Cell Rep Med. 2023 Aug 15;4(8):101160. doi: 10.1016/j.xcrm.2023.101160.

DOI:10.1016/j.xcrm.2023.101160
PMID:37586319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10439277/
Abstract

VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a pleiotropic, severe autoinflammatory disease caused by somatic mutations in the ubiquitin-like modifier activating enzyme 1 (UBA1) gene. To elucidate VEXAS pathophysiology, we performed transcriptome sequencing of single bone marrow mononuclear cells and hematopoietic stem and progenitor cells (HSPCs) from VEXAS patients. HSPCs are biased toward myeloid (granulocytic) differentiation, and against lymphoid differentiation in VEXAS. Activation of multiple inflammatory pathways (interferons and tumor necrosis factor alpha) occurs ontogenically early in primitive hematopoietic cells and particularly in the myeloid lineage in VEXAS, and inflammation is prominent in UBA1-mutated cells. Dysregulation in protein degradation likely leads to higher stress response in VEXAS HSPCs, which positively correlates with inflammation. TCR usage is restricted and there are increased cytotoxicity and IFN-γ signaling in T cells. In VEXAS syndrome, both aberrant inflammation and myeloid predominance appear intrinsic to hematopoietic stem cells mutated in UBA1.

摘要

VEXAS(空泡、E1 酶、X 连锁、自身炎症、体细胞)综合征是一种多系统、严重的自身炎症性疾病,由泛素样修饰酶激活酶 1(UBA1)基因的体细胞突变引起。为了阐明 VEXAS 的发病机制,我们对 VEXAS 患者的单个骨髓单核细胞和造血干细胞和祖细胞(HSPC)进行了转录组测序。HSPC 在 VEXAS 中偏向于髓系(粒细胞)分化,而不是淋巴系分化。在 VEXAS 中,多个炎症途径(干扰素和肿瘤坏死因子-α)在原始造血细胞中很早就发生了先天激活,特别是在髓系中,炎症在 UBA1 突变细胞中很明显。蛋白质降解的失调可能导致 VEXAS HSPC 中的应激反应增加,这与炎症呈正相关。TCR 的使用受到限制,T 细胞中的细胞毒性和 IFN-γ 信号增加。在 VEXAS 综合征中,UBA1 突变的造血干细胞中似乎存在异常炎症和髓系优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/1b9052220809/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/2dc933f5e996/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/c444839c3e8c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/2669ba8c02a8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/cdd28faf33a9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/0b50bcb02fdb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/db8bf41f126d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/8fb0a8eefa2b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/1b9052220809/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/2dc933f5e996/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/c444839c3e8c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/2669ba8c02a8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/cdd28faf33a9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/0b50bcb02fdb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/db8bf41f126d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/8fb0a8eefa2b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3791/10439277/1b9052220809/gr7.jpg

相似文献

1
Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS.UBA1 突变的造血干细胞和祖细胞中 VEXAS 炎症途径的早期激活。
Cell Rep Med. 2023 Aug 15;4(8):101160. doi: 10.1016/j.xcrm.2023.101160.
2
VEXAS syndrome.VEXAS综合征
Int J Hematol. 2024 May 31. doi: 10.1007/s12185-024-03799-9.
3
VEXAS Syndrome-Review.VEXAS综合征综述
Glob Med Genet. 2023 Jul 10;10(3):133-143. doi: 10.1055/s-0043-1770958. eCollection 2023 Sep.
4
Clinical Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: A Narrative Review.空泡、E1酶、X连锁、自身炎症性、体细胞(VEXAS)综合征的临床表现:一项叙述性综述
Cureus. 2024 Jan 27;16(1):e53041. doi: 10.7759/cureus.53041. eCollection 2024 Jan.
5
Thrombotic manifestations of VEXAS syndrome.VEXAS综合征的血栓形成表现
Semin Hematol. 2021 Oct;58(4):230-238. doi: 10.1053/j.seminhematol.2021.10.006. Epub 2021 Oct 25.
6
A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment.1例VEXAS综合征(空泡、E1酶、X连锁、自身炎症性、体细胞型)经口服泼尼松和托珠单抗治疗后氧化应激水平降低。
Front Med (Lausanne). 2022 Dec 5;9:1046820. doi: 10.3389/fmed.2022.1046820. eCollection 2022.
7
An update on VEXAS syndrome.VEXAS综合征的最新情况。
Expert Rev Clin Immunol. 2023 Feb;19(2):203-215. doi: 10.1080/1744666X.2023.2157262. Epub 2022 Dec 26.
8
Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.UBA1 体细胞突变和 VEXAS 综合征患者的特征性骨髓表现。
Semin Hematol. 2021 Oct;58(4):204-211. doi: 10.1053/j.seminhematol.2021.10.007. Epub 2021 Oct 22.
9
Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.UBA1 体细胞突变定义了 VEXAS 相关复发性多软骨炎的一个独特亚组患者。
Arthritis Rheumatol. 2021 Oct;73(10):1886-1895. doi: 10.1002/art.41743. Epub 2021 Aug 31.
10
Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?克隆性造血与VEXAS综合征:适者克隆生存?
Semin Hematol. 2021 Oct;58(4):226-229. doi: 10.1053/j.seminhematol.2021.10.004. Epub 2021 Oct 9.

引用本文的文献

1
Vacuolated Marrow Cytopenias from Copper Deficiency to -Mutant VEXAS: Molecular Landscape, Systematic Review, and Cost-Efficient Diagnostic Algorithm.从铜缺乏到突变型VEXAS的空泡性骨髓血细胞减少症:分子格局、系统评价及经济高效的诊断算法
Int J Mol Sci. 2025 Aug 20;26(16):8044. doi: 10.3390/ijms26168044.
2
Prevalence and outcome of VEXAS syndrome in unrelated hematopoietic cell transplantation for bone marrow failure.骨髓衰竭非亲缘造血细胞移植中VEXAS综合征的患病率及结局
Clin Exp Med. 2025 Aug 22;25(1):300. doi: 10.1007/s10238-025-01832-7.
3
VEXAS: A review of current understandings and emerging treatment strategies.

本文引用的文献

1
Spectrum of clonal hematopoiesis in VEXAS syndrome.VEXAS 综合征中的克隆性造血谱。
Blood. 2023 Jul 20;142(3):244-259. doi: 10.1182/blood.2022018774.
2
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.在临床人群中与 VEXAS 综合征相关的 UBA1 变异体的估计患病率和临床表现。
JAMA. 2023 Jan 24;329(4):318-324. doi: 10.1001/jama.2022.24836.
3
Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation.
VEXAS:当前认识与新兴治疗策略综述
Front Immunol. 2025 Jul 28;16:1644404. doi: 10.3389/fimmu.2025.1644404. eCollection 2025.
4
Is immunotherapy safe and effective in patients with VEXAS syndrome?免疫疗法对VEXAS综合征患者是否安全有效?
J Immunother Cancer. 2025 Jul 31;13(7):e012410. doi: 10.1136/jitc-2025-012410.
5
Promise of Jak Inhibition in the Management of VEXAS, Case Report with Review of the Literature.JAK抑制在VEXAS综合征治疗中的前景:病例报告及文献综述
Open Access Rheumatol. 2025 Jul 21;17:147-156. doi: 10.2147/OARRR.S531094. eCollection 2025.
6
Disease Trajectories and Glucocorticoid Exposure in VEXAS Syndrome Treated with Cytokine-Directed Therapies.细胞因子导向疗法治疗VEXAS综合征的疾病轨迹与糖皮质激素暴露情况
Ann Rheum Dis. 2025 Jun 27. doi: 10.1016/j.ard.2025.05.021.
7
VEXAS Syndrome and Alzheimer's Disease-Are There Connections?VEXAS综合征与阿尔茨海默病——存在关联吗?
Brain Sci. 2025 May 26;15(6):573. doi: 10.3390/brainsci15060573.
8
Clonal dominance: mutations in VEXAS syndrome take advantage of inflammation.克隆优势:VEXAS综合征中的突变利用炎症。
Nat Rev Rheumatol. 2025 Jun 6. doi: 10.1038/s41584-025-01270-5.
9
Human autoimmunity at single cell resolution in aplastic anemia before and after effective immunotherapy.再生障碍性贫血有效免疫治疗前后单细胞分辨率下的人类自身免疫。
Nat Commun. 2025 May 30;16(1):5048. doi: 10.1038/s41467-025-60213-6.
10
In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome.深度转录组分析描绘了VEXAS综合征患者功能失调的免疫反应图景。
Nat Commun. 2025 May 20;16(1):4690. doi: 10.1038/s41467-025-59890-0.
人类克隆性造血的单细胞多组学研究表明,DNMT3A R882 突变通过选择性低甲基化扰乱早期祖细胞状态。
Nat Genet. 2022 Oct;54(10):1514-1526. doi: 10.1038/s41588-022-01179-9. Epub 2022 Sep 22.
4
Single-cell roadmap of human gonadal development.人类性腺发育的单细胞图谱。
Nature. 2022 Jul;607(7919):540-547. doi: 10.1038/s41586-022-04918-4. Epub 2022 Jul 6.
5
Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells.单细胞 RNA 测序与大颗粒淋巴细胞白血病 T 细胞 TCR 谱分析的结合。
Nat Commun. 2022 Apr 11;13(1):1982. doi: 10.1038/s41467-022-29175-x.
6
Aging-elevated inflammation promotes DNMT3A R878H-driven clonal hematopoiesis.衰老引发的炎症促进了由DNMT3A R878H驱动的克隆性造血。
Acta Pharm Sin B. 2022 Feb;12(2):678-691. doi: 10.1016/j.apsb.2021.09.015. Epub 2021 Sep 22.
7
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.干细胞结构驱动骨髓增生异常综合征的进展,并预测对基于 venetoclax 的治疗的反应。
Nat Med. 2022 Mar;28(3):557-567. doi: 10.1038/s41591-022-01696-4. Epub 2022 Mar 3.
8
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis.一例与 EBV 相关噬血细胞性淋巴组织细胞增生症相关的 VEXAS 综合征。
Blood Cells Mol Dis. 2022 Mar;93:102636. doi: 10.1016/j.bcmd.2021.102636. Epub 2021 Nov 30.
9
VEXAS within the spectrum of rheumatologic disease.VEXAS在风湿性疾病范围内。
Semin Hematol. 2021 Oct;58(4):218-225. doi: 10.1053/j.seminhematol.2021.10.002. Epub 2021 Oct 9.
10
VEXAS syndrome: An inflammatory and hematologic disease.VEXAS综合征:一种炎症性血液疾病。
Semin Hematol. 2021 Oct;58(4):201-203. doi: 10.1053/j.seminhematol.2021.10.005. Epub 2021 Oct 14.